Skip to Content

Nadolol

In the US, Nadolol (nadolol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat Angina, Anxiety, Benign Essential Tremor, Esophageal Variceal Hemorrhage Prophylaxis, Glaucoma, High Blood Pressure, Lithium Tremor, Migraine Prevention, Mitral Valve Prolapse, Parkinsonian Tremor, Portal Hypertension and Supraventricular Tachycardia.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AA12

CAS registry number (Chemical Abstracts Service)

0042200-33-9

Chemical Formula

C17-H27-N-O4

Molecular Weight

309

Therapeutic Categories

Antihypertensive agent

Treatment of coronary heart disease

Antiarrhythmic agent

β-adrenoceptor antagonist (beta blocker), non-cardioselective

Chemical Names

1-(tert-Butylamino)-3-[(5,6,7,8-tetrahydro-cis-6,7-dihydroxy-1-naphtyl)oxy]-2-propanol (WHO)

2,3-Naphtalenediol, 5-[3-[(1,1-dimetyletyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-

Foreign Names

  • Nadololum (Latin)
  • Nadolol (German)
  • Nadolol (French)
  • Nadolol (Spanish)

Generic Names

  • Nadolol (OS: JAN, DCF, USAN, BAN)
  • Nadololo (OS: DCIT)
  • SQ 11725 (IS: Squibb)
  • Nadolol (PH: BP 2016, JP XVI, Ph. Eur. 8, USP 38)
  • Nadololum (PH: Ph. Eur. 8)

Brand Names

  • Apo-Nadol
    Apotex, Canada
  • Apo-Nadolol
    Apotex, New Zealand
  • Corgard
    Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, Venezuela; Pfizer U.S., United States; Sanofi, United Kingdom; Sanofi-Aventis, France
  • Corzide (Nadolol and Bendroflumethiazide)
    King Pharmaceuticals, United States
  • Nadic
    Dainippon Sumitomo Pharma, Japan
  • Nadololo Sanofi-Aventis
    Sanofi-Aventis, Italy
  • Solgol
    Sanofi Aventis, Spain
  • Teva-Nadolol
    Teva Canada, Canada

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide